共 50 条
- [3] Usefulness of monocytosis as biomarker to predict relapse in inflammatory bowel disease patients in remission under maintenance treatment with anti-TNF drugs: A prospective longitudinal cohort study [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S213 - S214
- [5] Lipid profile in inflammatory bowel disease under maintenance wih anti-TNF: a prospective longitudinal cohort study [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S180 - S180
- [9] Longitudinal Outcomes of Anti-TNF Therapy in the Treatment of Inflammatory Bowel Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S768 - S769
- [10] Infliximab but not adalimumab drug levels predict faecal calprotectin response in Inflammatory Bowel Disease patients on dose-intensified anti-TNF therapy [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S471 - S472